Maternal blood-cord samples from 171 women of middle socio-economic status who had been administered at least two doses of tetanus toxoid (TT), were assayed for tetanus antitoxins by passive haemagglutination (PHA) test AH the mother as well as cord samples had antitoxin titres &0.015 IU/ml, the generally accepted minimal protective level; 98 per cent of the mothers and 97 per cent of the newboms had levels 3=0.125 IU/ml. Transplacental dilution was observed hi 45 per cent of the samples; the cord/maternal antitoxin ratio (C/M) of geometric mean titre (GMT) was found to be 0.72. The C/M ratio was not affected by the maternal age, parity, birth weight, and number of TT doses administered to mother. The study showed that tetanus antitoxins were diluted on the fetal side of circulation, but the protective levels of antitoxins were achieved in all the newboms as the mothers had received at least two doses of TT before delivery.
Introduction
Neonatal tetanus (NNT) was a major public health problem before the Expanded Programme on Immunization was started in India in 1978. 1 ' 2 Follow-up surveys in 1989 and 1992 estimated the overall incidence as 4 and 1.74 per 1000 live births, respectively. 3 ' 4 Such a remarkable progress towards the ultimate goal of NNT elimination has been achieved largely through passive protection of newboms by active immunization of their mothers with aluminium-adsorbed tetanus toxoid (TT) during antenatal period. Recently, it has been shown that maternal tetanus antitoxins do not cross the placenta in a facilitative manner in women in Africa as it does in women in France, thereby leaving some children susceptible to NNT despite their mothers having protective antitoxin titres. 5 Keeping in view the importance of these findings, we carried out the present study to find out (i) whether antitoxin dilution across placenta occurs in India also and (ii) if so, whether it results in leaving some children susceptible to NNT despite adequate maternal tetanus antitoxin titres.
Materials and Methods
Maternal and cord blood samples were obtained from women admitted for delivery in two private maternity centres in Delhi during October 1993 to January 1995. The subjects were 18-38 years of age and belonged to middle socio-economic strata. All women were administered appropriately spaced two doses of aluminium phosphate adsorbed tetanus toxoid (5 Lf per dose) during the antenatal period. They were interviewed for age, parity, and TT immunization before the present pregnancy. History of primary immunization with DPT/DT during childhood was not ascertained because its authenticity was likely to remain doubtful in most of the cases in the absence of records. Entire pregnancy period was uneventful, and none had fever during pregnancy. Newborns were weighed by a lever balance.
Maternal blood samples were obtained by venepuncture when the mothers were admitted for delivery, whereas cord samples were collected at the time of delivery by expressing the umbilical cord contents into a sterile container. The samples were left at room temperature for about 1 h and then placed in a refrigerator at 2-8°C until transported to the laboratories of the National Institute of Same titres in 94 mother-cord pairs; one 2-foM dilution in 76 cord samples; two 2-fold dilution in one cord sample. Communicable Diseases, Delhi (NICD). The sera were separated and stored at -20°C till assayed for tetanus antitoxins by passive haemagglutination (PHA) test Table 1 , 98% of maternal sera (167/171) and 97% of cord sera (165/171) had tetanus antitoxin levels 5=0.125 IU/ml; none had levels less than 0.015 IU/ ml. Table 2 describes the maternal titres at different ages and parity and in relation to the number of TT doses administered. Significantly higher proportion of mothers who had two or more children (76 per cent) had antitoxin titres 3= 1 IU/ml than those having none (49 per cent) or one child (58 per cent). However, the titres were not significantly affected by the age of mothers. About 44 per cent of mothers who received two or three doses of TT had antitoxin titres & 1 IU/ml, whereas 67 and 73 per cent of mothers who received 4 or 5=5 doses of TT, respectively, had such a high level of titre.
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Results
As shown in
In Table 3 , the concentrations of tetanus antitoxins present in the cord sera are compared with maternal levels. The mean maternal and cord concentrations of antitoxins was 0.65 and 0.47 IU/ml, respectively; the ratio of cord/maternal antitoxins was found to be 0.72. The C/M ratio was not affected by the age of the mothers, parity, and birth weights. Lower antitoxin levels were found in 45% cord sera; the levels were same in the rest of (55 per cent) the pairs. In virtually all the samples, there was one case of 2-fold dilution; in only one sample, there were two cases of 2-fold dilution ( Table 4) .
Discussion
The results showed dilution of tetanus antitoxins on the fetal side of circulation. The cord/matemal ratio of antitoxins was found to be 0.72 which was not affected by the maternal age, parity, birth weight, and the number of TT doses administered (Table 3) . Although dilution occurred at even low titres, there were too few subjects to allow any definite conclusions to be made (Table 4) .
The findings are consistent with the earlier observations of Gendrel et al. that active placental transport of tetanus antibodies from mother to foetus may be impaired in developing countries than in developed countries. 5 The lack of active placental transfer of antibodies has been related to the excessively high maternal immunoglobulins as a result of continued anth genie stimulation which is common in developing countries (due to the exposure to a variety of clinical or subclinical infections), placental malaria, gestational age, and foetal growth.
"
7 Our subjects had no indication of malaria during pregnancy and other factors had no bearing on the placental transfer.
Although 6 per cent of the African newborns whose mother had been administered one dose of TT during pregnancy lacked protective levels of antitoxins despite some of the mothers having protective (but low) levels, a protective level was always obtained in mother as well as cord samples after two doses of TT. 5 In our series also, all the mothers had received at least two, usually more than three, doses of TT before present delivery. Despite transplacental dilution in 45 per cent of the cord sera, none of the newborns had tetanus antitoxins less than 0.015 IU/ml, the generally accepted minimum protective level. In fact, 97 per cent of them had antitoxin levels &0.125 IU/ml.
It may be argued that though correlation between the PHA test and the neutralization test is generally high, the former is more sensitive in detecting non-protective IgM antibodies than protective IgG antibodies and, therefore, may show falsely increased titres after the first or second dose of toxoid, especially at low levels of antibodies. 8 ' 9 However, all of our mothers had received more than two doses of TT and the studies on placental transfer have demonstrated that only the IgG class of immunoglobulins is transferred from the mother to the fetus. 10 Therefore, all the immunoglobulins assayed by the PHA in cord sera are likely to be IgG rather than IgM. Moreover, most of the cord sera had high antitoxin titres, i.e. 2=0.125 IU/ml. The results, therefore, suggest that despite transplacental dilution of tetanus antitoxins on the fetal side of circulation, protective levels of antitoxins are still achieved in all the newborns provided mothers are adequately immunized.
